Skip to main content
logo
Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
83.85
+0.12 (0.14%)
Jul 27, 2026, 4:00 PM EDT - Market closed

Crinetics Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-496.39-465.32-298.41-214.53-163.92-107.64
Depreciation & Amortization
4.133.892.791.10.980.92
Stock-Based Compensation
100.2391.0269.3940.9428.2717.35
Other Adjustments
-10.31-12.36-11.37-1.860.85-0.32
Change in Receivables
--0.59----
Changes in Inventories
--2.02----
Changes in Accounts Payable
0.4528.9813.3212.3610.996.29
Changes in Unearned Revenue
-1.9-1.840.07-1.548.34-
Changes in Other Operating Activities
-19.58-19.69-5.98-5.07-0.72-5.2
Operating Cash Flow
-414.17-377.92-230.19-168.6-115.21-88.59
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-5.34-5.76-3.84-4.69-1.66-0.44
Purchases of Investments
-1,168-1,004-1,147-532.86-329.82-125.4
Proceeds from Sale of Investments
1,1811,184575.8337.13157.4969.36
Investing Cash Flow
7.51173.91-574.82-200.41-173.98-56.48

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
390.4540.611,030391.78121.96252.68
Net Common Stock Issued (Repurchased)
390.4540.611,030391.78121.96252.68
Other Financing Activities
-0.58--14.98-0.54--
Financing Cash Flow
426.0540.611,015391.24121.96252.68

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
--0.11----
Net Cash Flow
19.39-163.4209.6522.22-167.22107.61

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-419.52-383.68-234.04-173.29-116.86-89.02
Free Cash Flow Growth
------
FCF Margin
-35733.90%-4985.50%-22525.30%-4318.12%-2466.98%-8258.26%
Free Cash Flow Per Share
-4.33-4.08-2.90-2.98-2.25-2.32
Levered Free Cash Flow
-518.64-461.76-292.06-212.37-145.98-106.06
Unlevered Free Cash Flow
-567.99-513.41-332.5-220.45-149.94-106.12
SEC Filings: 10-K · 10-Q